Skip to content

13F-HR filed by Athyrium Capital Management, LP

Athyrium Capital Management, LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-12, with 2 holding rows worth $8,686,216.

Accession
0001123292-24-000336
Filed
2024-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 2 entries on the cover page, a total value of $8,686,216 stated on the cover page (in dollars after the unit check, H1), rows summing to $8,686,216 with VALUE read as dollars as filed, 13F file number 028-18509. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIORA THERAPEUTICS INC74319F305COM10,929,762$5,482,368dollars as filed
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK1,256,411$3,203,848dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001123292-24-000336this filing2024-11-12acceptance time not in the bulk data set